Oniria Therapeutics
PrivateLast Round
Grant
Dec 16, 2025
Total Funding Raised
$5.69M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Oniria Therapeutics operates in Healthcare & Life Sciences and is based in Barcelona. Its latest recorded funding round was a Grant round in December 2025.
Oniria Therapeutics is a biotechnology company that develops precision oncology therapies designed to counteract cancer resistance and combat disease relapse.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Government Contracts, Revenue Share
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Oniria Therapeutics Comparables
Compare Oniria Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hemispherian AS | 83% | |
| HiberCell | 75% | |
| Otsuka Holdings | 61% |
For institutional investors. Book with your work email.
Oniria Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Dec 16, 2025 | ||||
| Grant | May 8, 2025 | ||||
| Seed | May 11, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Oniria Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Union | Grant |
| BStartup Banco Sabadell | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 63% MoM.
- Dec 16, 2025
$2M raised from the European Union.
For institutional investors. Book with your work email.
Oniria Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Oniria Therapeutics's valuation, stock price, and market status.
Is Oniria Therapeutics a public or private company?
Oniria Therapeutics is a private company.
What is the current stock price of Oniria Therapeutics?
Oniria Therapeutics is a private company, so its shares have no public market price. Caplight tracks Oniria Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Oniria Therapeutics worth (valuation)?
Valuation information for Oniria Therapeutics is not publicly available.
Can I buy Oniria Therapeutics stock?
Oniria Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Oniria Therapeutics's last funding round?
Oniria Therapeutics's most recent funding round was Grant on December 16, 2025.
Who are the main investors in Oniria Therapeutics?
Key investors in Oniria Therapeutics include European Union, BStartup Banco Sabadell.
Will Oniria Therapeutics IPO soon?
No public IPO plans have been announced for Oniria Therapeutics.
How can I track Oniria Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Oniria Therapeutics's shares on secondary markets.